RNS - weird investment. High costs of compliance. Barriers to entry. Waste of time?? 12% will be peanuts
Certainly peanuts with AMED! They only released their RNS the day before so Leg could beef up their own!
CC, I am sure I am right in thinking that the CEO has options at .2p. This means he doesn't start making money until the sp rises ABOVE .2p, and imo he wont sell once the bulls pile in.
Amedeo have completed the 'physical build' of the rig on time. Testing to be completed and delivery made in 2016.
Intermevan: the ceo has options at .2p. He wont make any money unless it rises above .2p. He's not going to sell even when it reached .3p, because by that time the target will be .5p or more.
Been watching this one for a while from the sidelines after getting burnt directly with Amedeo. Have seen too many of these large rises!
This beets me. The market can be irrational for a long time; but it is never irrational for ever; and when the switch occurs its likely to overshoot by just as much as it is undershooting.
This can only be good. On a fundamental analysis, VS alone is worth £4m, and the other pieces ... Mkt cap remains at £2.5m!
Latest from the Community...
Latest from the Community...
Latest from the Community...